Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Mayne Pharma Group Limited

MAYNF•PNK
Healthcare
Drug Manufacturers - General
$1.86
$0.005(0.27%)
U.S. Market opens in 6h 51m

Mayne Pharma Group Limited (MAYNF) Stock Overview

Explore Mayne Pharma Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap150.7M
P/E Ratio-2.16
EPS (TTM)$-0.79
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$2.89
3 Months$3.49
1 Year Target$3.22

MAYNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mayne Pharma Group Limited (MAYNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.16 and a market capitalization of 150.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.37%
5-Day Change
1.37%
1-Month Change
-7.71%
3-Month Change
-31.30%
6-Month Change
-43.62%
Year-to-Date (YTD) Change
-10.39%
1-Year Change
-59.67%
3-Year Change
-7.25%
5-Year Change
597.37%
All-Time (Max) Change
1764.32%

Contact Information

https://www.maynepharma.com
61 8 8209 2666
1538 Main North Road, Salisbury South, SA, 5106

Company Facts

4,500 Employees
IPO DateMar 22, 2013
CountryAU
Actively Trading

Frequently Asked Questions